Donate Now
  • Research Completed
Discovering New Diagnostic Protein Markers for Sporadic Inclusion Body Myositis
SPIN-Project-PLS-image
Scientific Study Title:
Sporadic Inclusion Body Myositis Proteomics to Identify Novel Biomarkers (SPIN)
Start Date:
  • 2022
End Date:
  • 2024
Research Category
Tags
nB4gwXfkeDxxel-Iwqn8mTwII-x8zWIGATSn85yqSF0
May Y. Choi
Research Scientist, Rheumatology, MD FRCPC, MPH
IZqRUfb4kD70vhHP9wh1EFGh3b2_UCsFug1CZ5Q62tU
Valérie Leclair
Research Scientist, Rheumatology, MD, PhD, FRCPC
Marie Hudson- Website Headshot-400x400
Marie Hudson
Research Scientist, Rheumatology MD, MPH, FRCPC

Why do this research?

Reason For Research

Sporadic inclusion body myositis (sIBM) is a muscle disease that’s hard to diagnose because many patients don’t have clear biomarkers (detectable indicators in their blood). Currently, diagnosis relies on invasive muscle biopsies. Delays in diagnosis can result in patients who have severe disability by the time a diagnosis is made. To improve diagnosis and understanding of sIBM, we used advanced machine learning and mass spectrometry techniques to look for new biomarkers—specific proteins or antibodies that could help identify the disease.

Methodology

Execution of Research

We tested blood samples from 10 sIBM patients using a special array – HuProtTM – a tool for mapping antigen-specific immunity to find new autoantibodies (immune system proteins that mistakenly attack the body). We analyzed blood and muscle tissue samples from sIBM patients to discover new proteins associated with the disease, using a method called mass spectrometry. We used statistical methods and machine learning to pick out the most important biomarkers that distinguish sIBM from healthy controls. We also explored how these biomarkers might be involved in the disease development process, focusing on immune response, inflammation, and muscle degeneration.

Findings & Next Steps

We identified many new autoantibodies and proteins from the tests. Some key findings include:

  • Immune system changes: Certain markers related to the immune system were found to be different in sIBM patients, such as changes in complement proteins and increased inflammation markers.
  • Muscle function: We found markers related to muscle structure and function that were different in sIBM patients.

We also found that processes like cell death, immune response, and inflammation are more active in sIBM patients compared to healthy controls. There were also changes in how muscle contractions and related processes work in sIBM.

This information may help us diagnose SIBM earlier and improve our understanding of how it develops. These findings need to be tested in more patients before they can be used in clinical practice.

We are working to confirm our findings by testing the new biomarkers in a larger group of sIBM patients.

Related Publications

  1. Moghaddam F, Tarnopolsky M, Leclair V, Hudson M, Mitchell R, Buhler K, Hatcher E, Zhang M, Fritzler M, Dufour A, de Almeida L, Choi M. (2024). Sporadic Inclusion Body Myositis Novel Autoantibody and Biomarker Research Utilizing Proteome Microarray and Mass Spectrometry Proteomics Analysis. 5th Global Conference on Myositis (GCOM), 42, 500 – 501. https://doi.org/https://‍‌‌‌doi.org/10.55563/clinexprheumatol/byxxv1
  2. Moghaddam F, Tarnopolsky M, Leclair V, Hudson M, Mitchell R, Buhler K, Hatcher E, Zhang M, Dufour A, de Almeida L, Fritzler M, Choi M. Sporadic Inclusion Body Myositis Novel Autoantibody and Biomarker Research Utilizing Proteome Microarray and Mass Spectrometry Proteomics Analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/sporadic-inclusion-body-myositis-novel-autoantibody-and-biomarker-research-utilizing-proteome-microarray-and-mass-spectrometry-proteomics-analysis/ .

Related Research

VIVA-Study-PLS-image

Intervention virtuelle pour les fractures vertébrales (VIVA) : un programme de réadaptation pour un meilleur rétablissement après une fracture vertébrale

Read More
Connecting Voices-PLS-715 x 405

Connecting Voices for Equitable Rheumatoid Arthritis Care Access

Read More
New Model of At-Home Follow-Up Care_PLS

A New Model of At-Home Follow-Up Care for Rheumatoid Arthritis

Read More
Research-EDI-Study_425x296

Improving Equity, Diversity, and Inclusion (EDI) in Arthritis Research

Read More
VIVA-Study-PLS-image

Virtual Intervention for Vertebral frActure (VIVA): A rehab program for better recovery after spine fractures

Read More
Other-Types-of-Arthritis-10.0-1

Improving quality of arthritis care for Indigenous populations

Read More